These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6695818)
1. Interaction of flecainide with digoxin and propranolol. Lewis GP; Holtzman JL Am J Cardiol; 1984 Feb; 53(5):52B-57B. PubMed ID: 6695818 [TBL] [Abstract][Full Text] [Related]
2. The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levels. Weeks CE; Conard GJ; Kvam DC; Fox JM; Chang SF; Paone RP; Lewis GP J Clin Pharmacol; 1986 Jan; 26(1):27-31. PubMed ID: 3950050 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol. Stern H; Scheininger M; Theisen F; Theisen K Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784 [TBL] [Abstract][Full Text] [Related]
4. [Diltiazem and digoxin interaction. Development of digoxin plasma levels and electrocardiographic parameters in healthy subjects]. Gallet M; Aupetit JF; Lopez M; Manchon J; Lestaevel M; Lefrançois JJ Arch Mal Coeur Vaiss; 1986 Jul; 79(8):1216-20. PubMed ID: 3096248 [TBL] [Abstract][Full Text] [Related]
5. Effect of intravenous digoxin on the heart at rest and during isometric exercise: a noninvasive study in normal and autonomically blocked volunteers. Partanen J J Cardiovasc Pharmacol; 1988 Feb; 11(2):158-66. PubMed ID: 2452309 [TBL] [Abstract][Full Text] [Related]
6. Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide. Donovan KD; Dobb GJ; Coombs LJ; Lee KY; Weekes JN; Murdock CJ; Clarke GM Am J Cardiol; 1991 Jan; 67(2):137-41. PubMed ID: 1898998 [TBL] [Abstract][Full Text] [Related]
7. The effect of a new antiarrhythmic agent, flecainide acetate, on systolic time intervals. Muhiddin KA; Shaw E; Blackett A; Patel L; Turner P Eur J Clin Pharmacol; 1983; 25(1):13-8. PubMed ID: 6617715 [TBL] [Abstract][Full Text] [Related]
8. Application of second-order polynomial equations to the study of pharmacodynamic interactions: the effect of flecainide acetate and propranolol on cardiac output and vascular resistance. Holtzman JL; Berry DA; Kvam DC; Mottonen L; Borrell G J Pharmacol Exp Ther; 1984 Nov; 231(2):286-90. PubMed ID: 6491982 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of flecainide. Conard GJ; Ober RE Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769 [TBL] [Abstract][Full Text] [Related]
10. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure. Mahgoub AA; El-Medany AH; Abdulatif AS Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction of sparfloxacin and digoxin. Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease. Legrand V; Vandormael M; Collignon P; Kulbertus HE Am J Cardiol; 1983 Feb; 51(3):422-6. PubMed ID: 6823856 [TBL] [Abstract][Full Text] [Related]
14. Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals. Kirch W; Logemann C; Heidemann H; Santos SR; Ohnhaus EE Eur J Clin Pharmacol; 1986; 31(4):391-5. PubMed ID: 3816917 [TBL] [Abstract][Full Text] [Related]
15. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia]. Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630 [TBL] [Abstract][Full Text] [Related]
16. The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance. Holtzman JL; Finley D; Mottonen L; Berry DA; Ekholm BP; Kvam DC; McQuinn RL; Miller AM Clin Pharmacol Ther; 1989 Jul; 46(1):26-32. PubMed ID: 2501057 [TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and side effects of flecainide acetate. Salerno DM; Granrud G; Sharkey P; Krejci J; Larson T; Erlien D; Berry D; Hodges M Clin Pharmacol Ther; 1986 Jul; 40(1):101-7. PubMed ID: 3720173 [TBL] [Abstract][Full Text] [Related]
18. Oral flecainide acetate for the treatment of ventricular arrhythmias. Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711 [TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients. Conard GJ; Cronheim GE; Klempt HW Arzneimittelforschung; 1982; 32(2):155-9. PubMed ID: 7199921 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. Kjekshus J; Bathen J; Orning OM; Storstein L Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]